Reduce Medication Errors by Translating AESOP Model Into CPOE Systems
NCT ID: NCT03484793
Last Updated: 2018-04-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
37 participants
INTERVENTIONAL
2017-05-01
2018-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Implementation of a Novel Computerized Physician Order Entry System
NCT00713297
A Trial for a Personalized Medication Management Platform to Improve Medication Adherence
NCT02197689
The General Objective of This Study is to Monitor, Assess, and Prevent the Potential Medication Errors Among Inpatients in the Tertiary Healthcare Facility of Nepal. This Study Aims to Develop and Implement the Medication Errors Reporting System in Hospital Settings.
NCT07002606
Reducing Medication Errors on Basis of an Individual Risk Assessment
NCT01814280
Integrated Novel Clinical Decision Support System (CDSS) in a Computerized Physician Order Entry System
NCT00904072
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AESOP integrated to CPOE for reducing medication errors
18 were assigned to the experimental group
AESOP service system
Investigators develop an electronic reminder in CPOE system which notifies physicians when there appears to be an inappropriate prescription. At the time, a physician saves a typed prescription, our system analyzes the patient's medications, diseases and uses the knowledge base to determine whether a medication is uncommonly prescribed to all diseases in a given prescription. If the system detects the common associations of medications and diseases in a given prescription, it considers an appropriate prescription, and, if not, an actionable reminder is shown onscreen. To the right of each suggested uncommon medication is a reason why the reminder is appearing. Physicians can accept the reminder or ignore the reminder.
Non AESOP
19 were assigned to the traditional CPOE system
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AESOP service system
Investigators develop an electronic reminder in CPOE system which notifies physicians when there appears to be an inappropriate prescription. At the time, a physician saves a typed prescription, our system analyzes the patient's medications, diseases and uses the knowledge base to determine whether a medication is uncommonly prescribed to all diseases in a given prescription. If the system detects the common associations of medications and diseases in a given prescription, it considers an appropriate prescription, and, if not, an actionable reminder is shown onscreen. To the right of each suggested uncommon medication is a reason why the reminder is appearing. Physicians can accept the reminder or ignore the reminder.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Physicians who sign the consent form
Exclusion Criteria
* Physicians who do not sign the consent form
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry of Science and Technology, Taiwan
OTHER_GOV
Taipei Medical University Shuang Ho Hospital
OTHER
Taiwan College of Healthcare Executives
UNKNOWN
Taipei Medical University Taipei Municipal Wan Fang Hospital
UNKNOWN
Case Western Reserve University
OTHER
Cardinal Tien Hospital
OTHER
Yong He Cardinal Tien Hospital
UNKNOWN
Chang Hua Christian Hospital
UNKNOWN
Taipei Medical University Hospital
OTHER
Taipei Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yu-Chuan MD Li, PhD
Role: STUDY_CHAIR
Taipei Medical University
Chuya Huang, MA
Role: STUDY_DIRECTOR
Taipei Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
TMU-Shuang-Ho Hospital
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NSC105-2634-F-038-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.